Cancers Among the Young Are Rising Worldwide
WEDNESDAY, Sept. 6, 2023 (HealthDay News) — Cancer is surging among people under 50, a new global study reveals.Over the past 30 years, new cases have increased 79% worldwide in that age bracket, according to a report published Sept. 5 in BMJ Oncolog…
Learn MoreFitter Folks Need Fewer Psychiatric Meds, Study Finds
WEDNESDAY, Sept. 6, 2023 (HealthDay News) — Being fit doesn’t just help your body — it also helps your mind, a new study reports.People in better physical condition appear to have less need for drugs to treat mood disorders, Norwegian researchers ha…
Learn MoreWeight Gain During Pregnancy: An Ob-Gyn Shares What You Need to Know
Pregnancy is a time filled with excitement and anticipation. While there are many things to look forward to, there’s one aspect that some women might concerned about: How much weight do you gain during pregnancy?This article will explore how much wome…
Learn MoreSleep Apnea Treatment Cuts Nighttime Heartburn, Respiratory Symptoms
TUESDAY, Sept. 5, 2023 (HealthDay News) — Treatment with positive airway pressure (PAP) for obstructive sleep apnea (OSA) for two years is associated with a decrease in nighttime heartburn and respiratory symptoms, according to a study published onli…
Learn MoreChronic Traumatic Encephalopathy Seen in Young, Deceased Athletes
TUESDAY, Sept. 5, 2023 (HealthDay News) — Among contact sport athletes younger than 30 years old at the time of death, chronic traumatic encephalopathy (CTE) was present in 41.4 percent of brains, according to a study published online Aug. 28 in JAMA…
Learn MoreCannabis May Be Tied to Increased Risk for Psychiatric Outcomes
TUESDAY, Sept. 5, 2023 (HealthDay News) — Cannabis should be avoided in adolescence and early adulthood and by people at risk for mental disorders, according to a review published online Aug. 30 in The BMJ.Marco Salmi, M.D., Ph.D., from University of…
Learn MoreApixaban Has Lower Bleeding Risk for Initial Anticoagulation for Venous Thromboembolism
TUESDAY, Sept. 5, 2023 (HealthDay News) — Apixaban has a lower bleeding risk than warfarin or rivaroxaban during initial treatment for patients with venous thromboembolism (VTE), according to a study published online Aug. 28 in the Journal of Interna…
Learn More